Trials / Active Not Recruiting
Active Not RecruitingNCT06516068
A Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy
A Multicenter, Randomized, Open-label Phase II Clinical Study on the Efficacy and Safety of HRS-1893 in Obstructive Hypertrophic Cardiomyopathy Subjects.
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Shandong Suncadia Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to evaluate the efficacy, and safety of HRS-1893 for obstructive hypertrophic cardiomyopathy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-1893 | HRS-1893 |
Timeline
- Start date
- 2024-08-11
- Primary completion
- 2024-11-18
- Completion
- 2025-08-01
- First posted
- 2024-07-23
- Last updated
- 2025-07-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06516068. Inclusion in this directory is not an endorsement.